TriMix Injection (PGE1/Papaverine HCl/Phentolamine Mesylate) 100mcg/30mg/3mg/mL INJECTABLE, 2.5 m...

FDA Recall #D-0116-2023 — Class II — December 30, 2022

Recall #D-0116-2023 Date: December 30, 2022 Classification: Class II Status: Terminated

Product Description

TriMix Injection (PGE1/Papaverine HCl/Phentolamine Mesylate) 100mcg/30mg/3mg/mL INJECTABLE, 2.5 mL Multiple-Dose vials, Rx Only, Compounded by: Akina Pharmacy, 23475 Rock Haven Way Suite 105, Sterling, VA 20166.

Reason for Recall

Lack of Assurance of Sterility

Recalling Firm

Northern VA Compounders PLLC — Sterling, VA

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

4 vials

Distribution

Nationwide in the USA

Code Information

Lot#: 11212022@7, Exp 1/5/2023

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated